ATE364619T1 - Tibolonformulierungen - Google Patents

Tibolonformulierungen

Info

Publication number
ATE364619T1
ATE364619T1 AT02784184T AT02784184T ATE364619T1 AT E364619 T1 ATE364619 T1 AT E364619T1 AT 02784184 T AT02784184 T AT 02784184T AT 02784184 T AT02784184 T AT 02784184T AT E364619 T1 ATE364619 T1 AT E364619T1
Authority
AT
Austria
Prior art keywords
tibolone
alpha
relates
formulations
tibolone formulations
Prior art date
Application number
AT02784184T
Other languages
English (en)
Inventor
Tom Brennan
Austin John Woolfe
Original Assignee
Norton Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26246675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE364619(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB0125061.2A external-priority patent/GB0125061D0/en
Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd
Application granted granted Critical
Publication of ATE364619T1 publication Critical patent/ATE364619T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Ceramic Products (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Powder Metallurgy (AREA)
AT02784184T 2001-10-18 2002-10-18 Tibolonformulierungen ATE364619T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0125061.2A GB0125061D0 (en) 2001-10-18 2001-10-18 Pharmaceutical composition
US35012101P 2001-11-02 2001-11-02

Publications (1)

Publication Number Publication Date
ATE364619T1 true ATE364619T1 (de) 2007-07-15

Family

ID=26246675

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02784184T ATE364619T1 (de) 2001-10-18 2002-10-18 Tibolonformulierungen

Country Status (10)

Country Link
EP (1) EP1444247B1 (de)
AT (1) ATE364619T1 (de)
AU (1) AU2002347973A1 (de)
CY (1) CY1106754T1 (de)
DE (1) DE60220699T2 (de)
DK (1) DK1444247T3 (de)
ES (1) ES2284946T3 (de)
MX (1) MXPA04003588A (de)
PT (1) PT1444247E (de)
WO (1) WO2003032924A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1499278B1 (de) * 2003-05-23 2005-06-01 Akzo Nobel N.V. Schnell freisetzende farmazeutische darreichungsform enthaltend polymorphes tibolon
WO2005084682A1 (en) * 2004-03-08 2005-09-15 Pharmaceutical Services Inc. (Psi Nv.) Pharmaceutical composition comprising cyclodextrin complex of tibolone
WO2005117899A1 (en) * 2004-06-02 2005-12-15 Cipla Limited Pharmaceutical composition comprising tibolone and process for procuding the same
WO2017191266A1 (en) 2016-05-04 2017-11-09 Mithra Pharmaceuticals S.A. Use of sugar-alcohols in tibolone compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
DE69418744T2 (de) * 1993-03-05 1999-11-11 Akzo Nobel Nv Verwendung von Pregnanderivaten zur Behandlung von Tumoren

Also Published As

Publication number Publication date
DE60220699D1 (de) 2007-07-26
EP1444247A2 (de) 2004-08-11
CY1106754T1 (el) 2012-05-23
PT1444247E (pt) 2007-07-09
MXPA04003588A (es) 2005-04-11
WO2003032924A2 (en) 2003-04-24
EP1444247A4 (de) 2004-12-08
WO2003032924A3 (en) 2004-01-29
DE60220699T2 (de) 2008-03-06
DK1444247T3 (da) 2007-09-24
ES2284946T3 (es) 2007-11-16
EP1444247B1 (de) 2007-06-13
AU2002347973A1 (en) 2003-04-28

Similar Documents

Publication Publication Date Title
EA200100713A1 (ru) Препаративная форма галантамина с регулируемым выделением
IL153406A0 (en) Cyclopentanoindoles, compositions containing such compounds and methods of treatment
AU3652102A (en) Compounds and their uses
DK1200418T3 (da) Nematodicide trifluorbutener
MXPA03010909A (es) Derivados de epotilona.
BR0215405A (pt) Composições e processos de uso de collajolie
HK1044349B (zh) 含有1，1，1，3，3-五氟丁烷的組合物及此種組合物的用途
DE50202328D1 (de) Amidofunktionelle aminopolydiorganosiloxane
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
ATE314084T1 (de) Kahalalid f formulierung
MXPA03011128A (es) Composicion de sabor y fragancia.
PT1204659E (pt) Benzofuranos serotoninergicos
DK1444247T3 (da) Tibolonformuleringer
BR0011261B1 (pt) composiÇço oral compreendendo perlita, e, uso de perlita.
SE9904128D0 (sv) Novel compounds
ITMI20001695A0 (it) Procedimento per la preparazione di composizioni organico-sili-coniche.
MXPA03010821A (es) Composiciones de aroma y fragancias.
CY1111290T1 (el) Παραγωγα 9-αλκυλαμινo-1-νιτρoακριδινης
MXPA03001440A (es) Compuestos de trioxepano novedosos.
ECSP003412A (es) Derivados de 3- amino -3-arilpropan - 1 - ol, su preparacion y su uso

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1444247

Country of ref document: EP